The present data demonstrated that the expression status of topoIIα might be identical to that of HER2, showing common expression in cases of de novo salivary duct carcinoma and in malignant components from carcinoma ex pleomorphic adenoma. This evidence concerns the gene ERBB2 and salivary duct carcinoma.